Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells. [electronic resource]
Producer: 19901207Description: 7318-23 p. digitalISSN:- 0008-5472
- Ascites
- Carcinoma -- immunology
- Cytokines -- biosynthesis
- Cytotoxicity, Immunologic
- Female
- HLA-D Antigens -- metabolism
- Histocompatibility Antigens Class I -- metabolism
- Humans
- Immunity, Cellular
- Injections, Intraperitoneal
- Interferon-gamma -- administration & dosage
- Ovarian Neoplasms -- immunology
- Recombinant Proteins
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.